Title: Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells.
Journal: The Journal of biological chemistry 20180216
Title: The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer.
Journal: Oncogene 20170105
Title: MCM5 as a target of BET inhibitors in thyroid cancer cells.
Journal: Endocrine-related cancer 20160401
Title: CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer.
Journal: The Journal of clinical investigation 20160201
Title: BET inhibitor resistance emerges from leukaemia stem cells.
Journal: Nature 20150924
Title: An epigenomic approach to therapy for tamoxifen-resistant breast cancer.
Journal: Cell research 20140701
Title: Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.
Journal: Molecular cancer therapeutics 20140501
Title: Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.
Journal: Blood 20140130
Title: Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.
Journal: ACS medicinal chemistry letters 20130912
Title: Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.
Journal: Journal of medicinal chemistry 20130425
Title: Cancer research: Open ambition.
Journal: Nature 20120809
Title: From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.
Journal: Bioorganic & medicinal chemistry letters 20120415
Title: Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.
Journal: Journal of medicinal chemistry 20120126
Title: BET bromodomain inhibition as a therapeutic strategy to target c-Myc.
Journal: Cell 20110916
Title: Liver X receptors as regulators of macrophage inflammatory and metabolic pathways.
Journal: Biochimica et biophysica acta 20110801
Title: Discovery and characterization of small molecule inhibitors of the BET family bromodomains.
Journal: Journal of medicinal chemistry 20110609
Title: Suppression of inflammation by a synthetic histone mimic.
Journal: Nature 20101223
Title: Nicodeme E, et al. Suppression of inflammation by a synthetic histone mimic. Nature. 2010 Dec 23;468(7327):1119-23.
Title: Asangani IA, et al. Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer. Nature. 2014 Jun 12;510(7504):278-82.
Title: Chaidos A, et al. Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762. Blood. 2014 Jan 30;123(5):697-705.
